ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 199 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,180,000 | -73.9% | 589,311 | -47.2% | 1.35% | -78.0% |
| Q4 2021 | $31,298,000 | -17.4% | 1,115,411 | 0.0% | 6.14% | -12.5% |
| Q3 2021 | $37,913,000 | -16.8% | 1,115,411 | 0.0% | 7.02% | -11.9% |
| Q2 2021 | $45,576,000 | +1.5% | 1,115,411 | 0.0% | 7.97% | -9.8% |
| Q1 2021 | $44,906,000 | -31.9% | 1,115,411 | 0.0% | 8.83% | -41.0% |
| Q4 2020 | $65,954,000 | +21.6% | 1,115,411 | 0.0% | 14.96% | -3.1% |
| Q3 2020 | $54,242,000 | +0.5% | 1,115,411 | 0.0% | 15.44% | +3.7% |
| Q2 2020 | $53,964,000 | +74.2% | 1,115,411 | 0.0% | 14.89% | +43.0% |
| Q1 2020 | $30,986,000 | -7.2% | 1,115,411 | 0.0% | 10.41% | +9.8% |
| Q4 2019 | $33,373,000 | -3.2% | 1,115,411 | 0.0% | 9.48% | -27.4% |
| Q3 2019 | $34,466,000 | – | 1,115,411 | – | 13.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |